(1 - 13 from 15
)
Pfizer's arthritis drug tofacitinib to receive positive FDA AdCom ...
www.ft.com
[Financial Times] - While some rheumatologists expect concomitant lipid- lowering therapies to be required by the FDA, Dr David Sandoval, assistant professor of medicine in rheumatology, University of Washington, did not think this measure would be necessary.
sorted by relevance / date